Journal Home
Search for

Volume 52, Issue 4, Pages 792-795 (October 2008)


View previous. 31 of 44 View next.

A Case of Cocaine-Induced Acute Interstitial Nephritis

David Wojciechowski, DO,1Corresponding Author Informationemail address, Bhaskar Kallakury, MD,2, Pouneh Nouri, MD1

Received 18 October 2007; accepted 19 March 2008. published online 13 May 2008.

Article Outline

Case Report

Clinical History

Kidney Biopsy

Diagnosis

Clinical Follow-up

Discussion

Acknowledgment

References

Copyright

Acute interstitial nephritis (AIN) is a well known but often overlooked cause of acute kidney injury (AKI).1 AIN is discovered on 15% of biopsy samples obtained in the evaluation of acute renal failure.2 AIN may occur because of a variety of conditions, including systemic infections and immune or immune-like inflammation and as a drug reaction. We present a case of drug-induced AIN secondary to a cocaine binge.

Case Report 

return to Article Outline

Clinical History 

A 38-year-old African American man with no prior medical history presented to an outside hospital's emergency department with right upper-quadrant pain of 3 days' duration. The patient admitted to binging on alcohol and cocaine for 5 to 7 days before presentation, but stopped the day before he presented to the emergency department. One day before the emergency department visit, the patient took 2 doses of ibuprofen, 600 mg, for the pain. The patient additionally reported nausea and decreased urine output. In the emergency department, creatinine (Cr) level was 12 mg/dL (1,061 μmol/L). Liver function test results were also increased, including aspartate aminotransferase level of 1,853 IU/L and alanine transaminase level of 7,012 IU/L.

On physical examination, the patient was awake and in mild distress secondary to abdominal discomfort. Blood pressure was 130/76 mm Hg, pulse was 76 beats/min, and oral temperature was 37°C. Fundoscopic examination findings were normal. The abdomen was tender in the midepigastric region and right upper quadrant. The liver was palpable 1 cm below the costal margin. There was no lower-extremity edema. Serum chemistry values were as follows: sodium, 127 mEq/L (127 mmol/L); potassium, 4 mEq/L (4 mmol/L); chloride, 93 mEq/L (93 mmol/L); bicarbonate, 15 mEq/L (15 mmol/L); blood urea nitrogen, 91 mg/dL (32.5 mmol/L); Cr, 13.2 mg/dL (1,167 μmol/L); calcium, 25.3 mg/dL (6.3 mmol/L); and phosphorus, 23.5 mg/dL (7.6 mmol/L). Urine toxicology screen was positive for cocaine. Urinalysis showed specific gravity of 1.015, 2+ protein, 4+ blood, negative nitrite and leukocyte esterase, and 10 to 15 white blood cells/high-power field. No casts or red blood cells were noted. A renal ultrasound showed the length of the right and left kidneys to be 14.2 and 13.4 cm without evidence of obstruction, respectively.

Additional laboratory testing results included positive urine eosinophils, positive human immunodeficiency virus (HIV) antibody, negative hepatitis B and C antibody, negative antinuclear antibody, intact parathyroid hormone level of 52 pg/mL (52 ng/L), hemoglobin A1c level of 5.8%, lactate dehydrogenase level of 733 IU/L, nonreactive rapid plasma reagin, negative urine protein electrophoresis, negative serum protein electrophoresis, and 24-hour urine protein excretion of 928 mg. Peak creatinine kinase (CK) level was 4,585 IU/L at presentation.

The patient was started on intravenous fluids during the next 24 hours. On hospital day 3, the patient continued to report nausea. Urine output remained at 50 to 75 mL/h, and the patient's Cr level was unchanged. The patient underwent a native kidney biopsy and was initiated on hemodialysis therapy.

Kidney Biopsy 

Tissue for light microscopy consisted of 1 core of renal cortex with 12 glomeruli. All glomeruli were viable; glomerular capillaries showed congestion, but no significant proliferative or necrotizing lesions (Fig 1A). Capillary basement membranes were not thickened. Blood vessels were unremarkable except for 1 interlobular artery showing prominence and bulging of the endothelium into the lumen, but no vasculitis (Fig 1B). The interstitium showed edema and a diffuse mixed inflammatory infiltrate including eosinophils (Fig 1C). Tubular epithelium showed reactive changes with mild degeneration, sloughed cells, and leukocytes in the lumen (Fig 1D and E). Many tubules showed necrotic luminal material with a polymorphonuclear leukocyte infiltrate (Fig 1F).


View full-size image.

Figure 1. (A) Hematoxylin and eosin–stained section shows interstitial inflammatory cell infiltrate in the cortex associated with edema and tubular injury. The 2 glomeruli show minor abnormalities. (B) Interlobular artery shows prominence and bulging of the endothelium into the lumen, but no vasculitis. (C, D, E) Interstitial edema and diffuse interstitial inflammatory cell infiltration with eosinophils (C, inset), tubules show degeneration with sloughed cells (D, E) and leukocytes (D) in the lumen. (F) Reactive tubule with cellular debris and some detached epithelial cells (arrows) in the lumen. Arrowhead points to an eosinophil with its characteristic vivid eosinophilic granular cytoplasm (original magnification: [A] ×100, [B to E] ×200, [F, inset in C] ×400).


Tissue submitted for direct immunofluorescence consisted of 5 glomeruli. No significant deposition of immunoglobulin G, immunoglobulin A, immunoglobulin M, C1q, or C3 was noted. Toluidine blue–stained thick sections were submitted for electron microscopy. This tissue consisted of only 1 glomerulus, which was viable and unremarkable. No tubuloreticular structures were identified.

Diagnosis 

Acute tubulointerstitial nephritis with admixed eosinophils suspicious for drug-induced AIN.

Clinical Follow-up 

The patient underwent hemodialysis on hospital days 4 and 5. As a result of the biopsy findings and persistently increased serum Cr level, the patient was started on prednisone therapy, 60 mg/d. On hospital day 6, serum Cr level began to decrease, and the nausea resolved. Hemodialysis therapy was withheld, and the patient was discharged on hospital day 8. On day 15, serum Cr level was 1.9 mg/dL (168 μmol/L). Prednisone therapy continued for a total of 4 weeks. Three months after the initial presentation, serum Cr level was 1.0 mg/dL (88.4 μmol/L).

Discussion 

return to Article Outline

When evaluating a patient with AKI, one must always be mindful that the cause may be multifactorial. Also, given the inherently complex nature of AKI, a systematic approach must be used. We attempted to work through the cause of this patient's AKI and will provide what we believe to be the most likely diagnosis.

The patient's recent cocaine use seemed a likely cause of AKI. The notion of AKI secondary to cocaine abuse is not a novel concept; 2 common causes are rhabdomyolysis and arterial hypertension induced by intense vasoconstriction.3, 4, 5 There are 3 substantiated mechanisms of renal failure caused by rhabdomyolysis: vasoconstriction with resultant ischemia, direct toxic effects of the myoglobin heme-protein on renal tubular cells, and intraluminal cast formation leading to mechanical obstruction.6 The patient clearly showed biochemical evidence of rhabdomyolysis. However, did the rhabdomyolysis completely account for the severity of the patient's AKI? The renal biopsy specimen and urine microscopy did not show casts to suggest intratubular obstruction. Also, unlike this patient, patients with renal failure caused by severe rhabdomyolysis are often oliguric. Additionally, changes seen in tubules were primarily inflammatory in nature, including infiltrating eosinophils. There were some mild tubular ischemic changes on the biopsy specimen, but no evidence of tubular necrosis to explain the AKI. Lastly, when factors predictive of AKI in patients with rhabdomyolysis were evaluated, the majority of patients who developed AKI were older (mean age, 53.7 years) and had a peak CK level greater than 16,000 U/L.7 The patient in this case was younger and had a lower peak CK level. CK levels decrease approximately 39% per day in healthy persons, but are prolonged in patients with renal failure.8 CK levels typically peak in 24 to 36 hours after the onset of rhabdomyolysis.8 It is unlikely that a significantly greater CK level was missed because the patient was actively using cocaine 2 days before presentation.

Acute cocaine toxicity also may lead to vasoconstriction of the renal vasculature with resultant medullary hypoxia and tubular ischemia.4 Two such examples have been reported in the literature.4, 5 In these cases, renal function returned to normal within 10 days or less, suggesting a more self-limited process.4, 5 Our patient showed evidence of mild vasoconstriction on the biopsy specimen, which, in addition to rhabdomyolysis, accounts for the tubular ischemic changes. However, this patient's Cr level was still increased at day 15, suggesting more than transient vasoconstriction and ischemia as the sole cause of AKI.

Given the recent drug exposure, nonoliguria, and eosinophiluria, AIN also was considered in the differential diagnosis. It is important to remember that the classic triad of fever, rash, and eosinophilia is present in only one third of patients with drug-induced AIN, and the absence of these findings should not be used to exclude the diagnosis.9 The biopsy specimen was consistent with the diagnosis of AIN, showing tubulointerstitial nephritis with admixed eosinophils. But what was the offending agent? The patient admitted to ibuprofen use; however, the overall presentation was not typical for nonsteroidal anti-inflammatory drug (NSAID)-induced AIN. In a retrospective study by Schwarz et al,10 it was found that NSAID-induced AIN was more likely to result in nephrotic-range proteinuria compared with other causes of AIN (38% versus 14%, respectively). Additionally, NSAID exposure occurred within 24 hours of the initial presentation to the hospital. In most cases of NSAID-induced AIN, the exposure to NSAIDS is present for a much longer period, often several weeks to months, before developing AKI.10, 11 Lastly, NSAID-induced AIN typically presents with a 1:2 man-woman ratio, with a mean age of 60 years.11 The patient did not fulfill any of the typical characteristics for NSAID-induced AIN.

We reconsidered the patient's heavy cocaine abuse as a cause of AKI. Two reports were identified in the literature of AIN caused by cocaine use.12, 13 In both cases, the AKI was preceded by heavy cocaine abuse, which required a short course of hemodialysis therapy. The 2 prior reported cases also resulted in complete renal recovery. In the report by Decelle et al,13 prednisone therapy was also initiated with a serum Cr level of 1.7 mg/dL on day 9. In the report by Alvarez et al,12 the patient declined prednisone therapy because of concerns of weight gain, and serum Cr level was still greater than 10 mg/dL at week 4. The role of steroids in AIN is not completely clear. There have been no true prospective randomized trials assessing the efficacy of steroids. In a study by Galpin et al,14 the addition of prednisone, 60 mg/d, hastened the recovery of renal function compared with patients who did not receive prednisone (9.3 versus 54 days, respectively). Given the lack of prospective data for AIN, it is difficult to make a determination on the role of steroid therapy in renal recovery.

Lastly, given the newly diagnosed HIV status, we also wanted to exclude any possibility of concomitant HIV-associated nephropathy (HIVAN). HIVAN typically is associated with both proliferative and apoptotic changes on the renal biopsy specimen, both of which were absent in this patient.15 Additionally, no viral inclusions were noted and no tubuloreticular structures were identified. HIVAN typically presents with nephrotic-range proteinuria, which was absent in our patient.15 However, the patient was noted to have enlarged kidneys on ultrasound. It traditionally has been believed that patients with HIVAN and those with AIN may present with enlarged kidneys. However, a recent cross-sectional study by Atta et al16 showed in an HIV-positive patient population that underwent kidney biopsy for evaluation of renal disease that kidney size on ultrasound was not associated with HIVAN status. Conversely, a study by Pusey et al17 showed that 78% of patients with drug-associated AIN had radiological evidence of enlarged kidneys.

When faced with the diagnosis of AKI, a broad differential diagnosis must be considered because multiple potential causes often are present. In this case, we believe that although the cause of AKI was multifactorial, drug-induced AIN accounted for the majority of the renal injury. Although there is no definitive way to establish causality between exposure to cocaine and the development of AIN, we believe that cocaine was the most likely culprit. When considering a diagnosis of AIN, a thorough drug history is always a prudent endeavor. A urine toxicology screen should be performed, and if cocaine-induced AIN is suspected, some consideration should be given to the use of corticosteroid therapy because it appears to hasten the recovery of renal function.

Acknowledgements 

return to Article Outline

We thank Maristela L. Onozato, Georgetown University Hospital, for her assistance in obtaining the pathology images.

Support: None.

Financial Disclosure: None.

References 

return to Article Outline

1. 1Michel DM, Kelly CJ. Acute interstitial nephritis. J Am Soc Nephrol. 1998;9:506–515. MEDLINE

2. 2Neilson EG. Pathogenesis and therapy of interstitial nephritis. Kidney Int. 1989;35:1257–1270. MEDLINE | CrossRef

3. 3Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000;11:1553–1561. MEDLINE

4. 4Leblanc M, Hebert MJ, Mongeau JG. Cocaine-induced acute renal failure without rhabdomyolysis. Ann Intern Med. 1994;121:721–722. MEDLINE

5. 5Amoedo ML, Craver L, Marco MP, Fernandez E. Cocaine-induced acute renal failure without rhabdomyolysis. Nephrol Dial Transplant. 1999;14:2970–2971. MEDLINE | CrossRef

6. 6Allison RC, Bedsole DL. The other medical causes of rhabdomyolysis. Am J Med Sci. 2003;326:79–88. MEDLINE | CrossRef

7. 7Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med. 1988;148:1553–1557. MEDLINE

8. 8Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine. 1982;61:141–152.

9. 9Appel GB, Kunis CL. Acute tubulo-interstitial nephritis. Contemp Issues Nephrol. 1983;10:151–185.

10. 10Schwarz A, Krause PH, Kunzendorf U, Keller F, Distler A. The outcome of acute interstitial nephritis: Risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol. 2000;54:179–190. MEDLINE

11. 11Kleinknecht D. Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. Semin Nephrol. 1995;15:228–235. MEDLINE

12. 12Alvarez D, Nzerue CM, Daniel JF, Faruque S, Hewan-Lowe K. Acute interstitial nephritis induced by crack cocaine binge. Nephrol Dial Transplant. 1999;14:1260–1262. MEDLINE | CrossRef

13. 13Decelle L, Cosyns JP, Georges B, Jadoul M, Lefebvre C. Acute interstitial nephritis after cocaine sniffing. Clin Nephrol. 2007;67:105–108. MEDLINE

14. 14Galpin JE, Shinaberger JH, Stanley TM, et al. Acute interstitial nephritis due to methicillin. Am J Med. 1978;65:756–765. Abstract | Full-Text PDF (2421 KB) | CrossRef

15. 15Herman ES, Klotman PE. HIV-associated nephropathy: Epidemiology, pathogenesis, and treatment. Semin Nephrol. 2003;23:200–208. Abstract | Full Text

16. 16Atta MG, Longenecker C, Fine DM, et al. Sonography as a predictor of human immunodeficiency virus-associated nephropathy. J Ultrasound Med. 2004;23:603–610. MEDLINE

17. 17Pusey CD, Saltissi D, Bloodworth L, Rainford DJ, Christie JL. Drug associated acute interstitial nephritis: Clinical and pathological features and the response to high dose steroid therapy. QJM. 1983;206:194–211.

1 Department of Internal Medicine, Division of Nephrology and Hypertension, Georgetown University Hospital, Washington, DC

2 Department of Pathology, Georgetown University Hospital, Washington, DC

Corresponding Author InformationAddress correspondence to David Wojciechowski, DO, Georgetown University Hospital, 3800 Reservoir Rd NW, 6-PHC, Washington, DC 20007

 Originally published online as doi:10.1053/j.ajkd.2008.03.018 on May 9, 2008.

PII: S0272-6386(08)00651-3

doi:10.1053/j.ajkd.2008.03.018


View previous. 31 of 44 View next.